![](https://news.europawire.eu/wp-content/uploads/2020/05/Rare-disease-Enhertu-of-AstraZeneca-and-Daiichi-Sankyo-now-with-Orphan-Drug-Designation-in-the-US-for-treatment-of-gastric-cancer-144x144.jpg)
(IN BRIEF) AstraZeneca will showcase new data from its industry-leading Oncology pipeline and portfolio at the American Association for Cancer Research Annual Meeting. A total of 70 presentations will be given, including a plenary presentation on the AEGEAN Phase III … Read the full press release